Literature DB >> 26098023

Response-adaptive randomization for multi-arm clinical trials using the forward looking Gittins index rule.

Sofía S Villar1,2, James Wason1, Jack Bowden1.   

Abstract

The Gittins index provides a well established, computationally attractive, optimal solution to a class of resource allocation problems known collectively as the multi-arm bandit problem. Its development was originally motivated by the problem of optimal patient allocation in multi-arm clinical trials. However, it has never been used in practice, possibly for the following reasons: (1) it is fully sequential, i.e., the endpoint must be observable soon after treating a patient, reducing the medical settings to which it is applicable; (2) it is completely deterministic and thus removes randomization from the trial, which would naturally protect against various sources of bias. We propose a novel implementation of the Gittins index rule that overcomes these difficulties, trading off a small deviation from optimality for a fully randomized, adaptive group allocation procedure which offers substantial improvements in terms of patient benefit, especially relevant for small populations. We report the operating characteristics of our approach compared to existing methods of adaptive randomization using a recently published trial as motivation.
© 2015 The Authors Biometrics published by Wiley Periodicals, Inc. on behalf of International Biometric Society.

Entities:  

Keywords:  Bayesian adaptive designs; Clinical trials; Gittins index; Multi-armed bandit; Sequential allocation

Mesh:

Year:  2015        PMID: 26098023      PMCID: PMC4856210          DOI: 10.1111/biom.12337

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  9 in total

1.  Optimal adaptive designs for binary response trials.

Authors:  W F Rosenberger; N Stallard; A Ivanova; C N Harper; M L Ricks
Journal:  Biometrics       Date:  2001-09       Impact factor: 2.571

2.  Bayesian adaptive randomized trial design for patients with recurrent glioblastoma.

Authors:  Lorenzo Trippa; Eudocia Q Lee; Patrick Y Wen; Tracy T Batchelor; Timothy Cloughesy; Giovanni Parmigiani; Brian M Alexander
Journal:  J Clin Oncol       Date:  2012-05-29       Impact factor: 44.544

3.  Adaptive assignment versus balanced randomization in clinical trials: a decision analysis.

Authors:  D A Berry; S G Eick
Journal:  Stat Med       Date:  1995-02-15       Impact factor: 2.373

4.  Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial.

Authors:  Luca Gianni; Tadeusz Pienkowski; Young-Hyuck Im; Laslo Roman; Ling-Ming Tseng; Mei-Ching Liu; Ana Lluch; Elżbieta Staroslawska; Juan de la Haba-Rodriguez; Seock-Ah Im; Jose Luiz Pedrini; Brigitte Poirier; Paolo Morandi; Vladimir Semiglazov; Vichien Srimuninnimit; Giulia Bianchi; Tania Szado; Jayantha Ratnayake; Graham Ross; Pinuccia Valagussa
Journal:  Lancet Oncol       Date:  2011-12-06       Impact factor: 41.316

5.  Bandit solutions provide unified ethical models for randomized clinical trials and comparative effectiveness research.

Authors:  William H Press
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

Review 6.  The use of response-adaptive designs in clinical trials.

Authors:  W F Rosenberger; J M Lachin
Journal:  Control Clin Trials       Date:  1993-12

7.  Multi-armed Bandit Models for the Optimal Design of Clinical Trials: Benefits and Challenges.

Authors:  Sofía S Villar; Jack Bowden; James Wason
Journal:  Stat Sci       Date:  2015       Impact factor: 2.901

8.  A comparison of Bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials.

Authors:  James M S Wason; Lorenzo Trippa
Journal:  Stat Med       Date:  2014-01-14       Impact factor: 2.373

Review 9.  Adaptive design methods in clinical trials - a review.

Authors:  Shein-Chung Chow; Mark Chang
Journal:  Orphanet J Rare Dis       Date:  2008-05-02       Impact factor: 4.123

  9 in total
  9 in total

1.  Generalisations of a Bayesian decision-theoretic randomisation procedure and the impact of delayed responses.

Authors:  S Faye Williamson; Peter Jacko; Thomas Jaki
Journal:  Comput Stat Data Anal       Date:  2022-10       Impact factor: 2.035

2.  Response adaptive designs for Phase II trials with binary endpoint based on context-dependent information measures.

Authors:  Ksenia Kasianova; Mark Kelbert; Pavel Mozgunov
Journal:  Comput Stat Data Anal       Date:  2021-06       Impact factor: 1.681

3.  Response-adaptive designs for binary responses: How to offer patient benefit while being robust to time trends?

Authors:  Sofía S Villar; Jack Bowden; James Wason
Journal:  Pharm Stat       Date:  2017-12-19       Impact factor: 1.894

4.  A Bayesian adaptive design for clinical trials in rare diseases.

Authors:  S Faye Williamson; Peter Jacko; Sofía S Villar; Thomas Jaki
Journal:  Comput Stat Data Anal       Date:  2016-09-28       Impact factor: 1.681

5.  Covariate-adjusted response-adaptive randomization for multi-arm clinical trials using a modified forward looking Gittins index rule.

Authors:  Sofía S Villar; William F Rosenberger
Journal:  Biometrics       Date:  2017-07-06       Impact factor: 2.571

6.  A response-adaptive randomization procedure for multi-armed clinical trials with normally distributed outcomes.

Authors:  S Faye Williamson; Sofía S Villar
Journal:  Biometrics       Date:  2019-09-19       Impact factor: 2.571

7.  Some performance considerations when using multi-armed bandit algorithms in the presence of missing data.

Authors:  Xijin Chen; Kim May Lee; Sofia S Villar; David S Robertson
Journal:  PLoS One       Date:  2022-09-12       Impact factor: 3.752

8.  Bayesian adaptive bandit-based designs using the Gittins index for multi-armed trials with normally distributed endpoints.

Authors:  Adam L Smith; Sofía S Villar
Journal:  J Appl Stat       Date:  2017-06-28       Impact factor: 1.404

9.  Personalized Risk-Based Screening Design for Comparative Two-Arm Group Sequential Clinical Trials.

Authors:  Yeonhee Park
Journal:  J Pers Med       Date:  2022-03-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.